Indication
Psychotic Disorders
8 clinical trials
9 products
2 drugs
Clinical trial
A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderStatus: Completed, Estimated PCD: 2022-09-23
Product
LY03010Clinical trial
A Study to Evaluate the PK Profiles of LY03010 and Relative Bioavailability at Steady-state of LY03010 Versus INVEGA SUSTENNA in Schizophrenia PatientsStatus: Completed, Estimated PCD: 2022-03-15
Product
Paliperidone palmitateProduct
Invega SustennaClinical trial
Striatal Connectivity and Clinical Outcome in PsychosisStatus: Completed, Estimated PCD: 2023-12-01
Product
Risperidone + AripiprazoleClinical trial
Cannabinoids, Learning, and MemoryStatus: Active (not recruiting), Estimated PCD: 2018-08-10
Product
THCProduct
PlaceboClinical trial
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective StudyStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Product
Psychiatric DrugsClinical trial
A Randomized Controlled Trial of Adjunctive Tocilizumab in SchizophreniaStatus: Recruiting, Estimated PCD: 2023-12-31
Drug
TocilizumabDrug
VarlilumabClinical trial
Determination of EEG Microstates Associated With Mental Disorders in At-Risk States (Détermination Des Microétats EEG associés Aux Troubles Psychiques Dans Les États à Risque - DEMETER)Status: Recruiting, Estimated PCD: 2026-07-30
Product
Biological samplingClinical trial
A Randomized Controlled Trial of Adjunctive Siltuximab in SchizophreniaStatus: Recruiting, Estimated PCD: 2023-12-31
Product
Siltuximab